Acaya 100 mg Capsule

Brand Name: Acaya

Molecule: Acalabrutinib

Strength: 100 mg

Quantity: 60 Capsules

Form: Capsule

Packaging Type: Bottle

Manufacturer/Marketed By: Zydus

Country of Origin: India

Description

Acaya 100 mg Capsule contains Acalabrutinib, a targeted anticancer medicine used to treat certain blood cancers. It helps slow cancer cell growth and disease progression under oncologist supervision.

Benefits

Targets cancer-causing B-cell pathways
Helps slow tumor growth and disease progression
May improve progression-free survival
Convenient oral capsule formulation
Widely used in modern hematologic oncology

Indications and Usage

Acaya 100 mg Capsule is indicated for:

Mantle Cell Lymphoma (MCL) in adults previously treated
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)

Therapy must be prescribed and supervised by an experienced oncologist.

How it Works

Acalabrutinib selectively blocks Bruton Tyrosine Kinase (BTK), an enzyme essential for B-cell cancer growth and survival. By inhibiting BTK, it disrupts cancer cell signaling, helping slow tumor progression.

Dosage & Administration

Typical dose: 100 mg twice daily, or as prescribed
Swallow capsules whole with water
Take at the same time every day
Do not crush, open, or chew capsules
Do not skip or double doses
Requires routine blood tests and clinical monitoring

Use only under oncologist supervision.

Side Effects

Common side effects:

Headache
Fatigue
Diarrhea
Muscle or joint pain
Easy bruising or bleeding

Serious side effects (seek urgent care):

Severe bleeding
Serious infections
Irregular heartbeat (atrial fibrillation)
Secondary cancers
Low blood cell counts

Warning and Precaution

Not recommended during pregnancy or breastfeeding
Use with caution in patients with bleeding disorders, heart disease, or liver issues
Avoid live vaccines during treatment
Increased infection risk — report fever immediately
Inform doctor about blood thinners or other medications
Stop and seek medical help if allergic symptoms occur

Osimertinib (Tagrisso) for Lung Cancer: What You Need to Know

Introduction Lung cancer is one of the most common and deadly cancers globally. The most common type of lung cancer is non-small

January 30, 2025

Rated 0 out of 5

0 reviews

Rated 5 out of 5

Rated 4 out of 5

Rated 3 out of 5

Rated 2 out of 5

Rated 1 out of 5

Reviews

Clear filters

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Product	Manufacturer / Marketed By	Price
Acalnib 100 mg Capsule	Hetero Healthcare	Ask for Price
Acaone 100 mg Capsule	Msn Laboratories India	Ask for Price
Acalaside 100 mg Capsule	Lucien Life Sciences	Ask for Price
Betatinib 100mg Capsule	Adley	Ask for Price
Acatinib 100 mg Tablet	Ziska Pharmaceuticals Ltd	Ask for Price

Call : +63 952 488 3302